Oral Presentations 18: Respiratory and Inflammation 3
Tracks
Track 2
| Wednesday, July 15, 2026 |
| 9:00 AM - 10:30 AM |
| Meeting Room 210 (Level 2) |
Speaker
Ms Liv Young
Monash University
AT2R agonists inhibit ECM production in an ex-vivo model of IPF-like fibrogenesis
9:00 AM - 9:15 AMBiography
Olivia Young is a researcher and member of the Bourke Lab within the Monash University Discovery Institute. Her work, likely within the Faculty of Medicine, Nursing and Health Sciences, focuses on areas within the biomedical or biological sciences, collaborating within a team specializing in chronic disease research.
Miss Elaine Koh
The University Of Melbourne
Fibroblast growth factor 2 in modulating Nintedanibs anti-fibrogenic efficacy in pulmonary fibroblasts
9:30 AM - 9:45 AMBiography
Elaine Koh is a student of the University of Melbourne of the Department of Biochemistry and Pharmacology.
Her honours year research focused on investigating anti-fibrotic drug efficacy in Idiopathic pulmonary fibrosis (IPF). This research characterised select interactions between Fibroblast growth factor 2 and a drug, Nintedanib, in influencing either pro- or anti-fibrogenic behaviour in pulmonary fibroblasts.
Mr Avanka Gunatilaka
The University of Melbourne
Mr Will Studley
Monash University
Vascular remodelling in an ex vivo lung model of pulmonary arterial hypertension
10:00 AM - 10:15 AMBiography
William Studley is a Biomedical Scientist and PhD student within the Department of Pharmacology at Monash University. Based in the Bourke Lab at the Monash Biomedicine Discovery Institute, his research focuses on pharmacological studies. He has contributed to research regarding small-molecule formyl peptide receptor agonists.
Session chair
Nurgul Ablakimova
West Kazakhstan Marat Ospanov Medical University
Jane Bourke
Monash University